Severe halothane (HAL)-induced hepatotoxicity occurs in one in 6000-30,000 patients by an unknown mechanism. Female sex is a risk factor in humans and rodents. We tested the hypothesis that a sex difference in natural killer (NK) cell activity contributes to HAL-induced liver injury. HAL (15 mmol/kg, ip) treatment resulted in severe liver injury by 12 h in female, wild-type BALB/cJ mice, and the magnitude of liver injury varied with stage of the estrous cycle. Ovariectomized (OVX) mice developed only mild liver injury. Plasma interferon-gamma (IFN-g) was elevated 10-fold in HAL-treated females compared with similarly treated male mice or with OVX female mice. IFN-g knockout mice were resistant to severe HAL-induced liver injury. The deactivation of NK cells with anti-asialo GM1 treatment attenuated liver injury and the increase in plasma IFN-g compared with immunoglobulin G-treated control mice. Mice with a mutated form of perforin, a protein involved in granule-mediated cytotoxicity, were protected from severe liver injury. Furthermore, HAL increased the activity of NK cells in vivo, as indicated by increased surface expression of CD69, an early activation marker. In response to HAL, NK cell receptor ligands on the surface of hepatocytes were expressed in a manner that can activate NK cells. These results confirm the sexual dimorphic hepatotoxic response to HAL in mice and suggest that IFN-g and NK cells have essential roles in the development of severe HAL-induced hepatotoxicity.
Drug-induced liver injury is the leading cause of acute liver failure in the United States (Ostapowicz et al., 2002) and the leading cause of withdrawal of U.S. Food and Drug Administration-approved drugs. Some of these hepatotoxic responses are classified as idiosyncratic adverse drug reactions (IADRs), which account for up to 20% of cases of severe liver injury requiring hospitalization (Lee, 2008) . IADRs often occur in a small fraction of people undergoing drug therapy, and the reactions are typically unrelated to the pharmacology of the drug. It is likely that the mechanisms of IADRs are multifactorial, and their rarity and complex mechanisms of development are barriers to the ability to predict in preclinical testing which drugs will produce them. Information gained from mechanistic studies using animal models that reproduce the injury seen in patients would be helpful to prevent and treat IADRs.
Halothane (HAL) is an inhaled anesthetic that produces mild liver injury in one in five patients (Trowell et al., 1975) and a more severe IADR, or ''HAL hepatitis,'' in one in 6000-30,000 patients exposed to the drug (Mushin et al., 1971) . HAL is metabolized by cytochrome P450 (CYP) 2E1 in hepatocytes to form trifluoroacetyl (TFA) chloride, which binds covalently to proteins and lipids, forming TFA adducts. Studies in which HAL hepatotoxicity in guinea pigs was ameliorated by SKF-525A, a CYP inhibitor, and exacerbated by 4-methylpyrazole, a CYP2E1 inducer, illustrate the requirement for metabolism in the development of hepatotoxicity (Farrell et al., 1996; Lunam et al., 1985) . Furthermore, susceptibility to HAL hepatotoxicity in a guinea pig model correlated with the formation of liver TFA protein adducts (Bourdi et al., 2001) . This suggests that TFA adducts are a prerequisite for pathogenesis; however, the mechanisms of pathogenesis for the mild and severe forms of HAL hepatotoxicity remain elusive. Hypotheses to explain the pathogenesis have been proposed; however, none has satisfactorily explained the characteristics of HAL hepatitis in human patients.
Female sex is a risk factor for IADRs from numerous drugs, including isoniazid, HAL, flucloxacillin, nitrofurantoin, and chloropromazine (Chalasani and Bjornsson, 2010) . It was recently reported that females were the most at-risk group, representing 81% of patients who developed severe HAL hepatitis (Eghtesadi-Araghi et al., 2008) . In mouse models of either mild or severe HAL hepatotoxicity, female mice developed liver injury at doses of HAL that produced no or minimal injury in male mice, and this disparity was not due to differences in HAL bioactivation You et al., 2006) . The accumulation and activity of innate immune cells, such as natural killer (NK) cells, are influenced by sex hormones (Curran et al., 2001) . In this regard, we demonstrated that HAL-treated female mice had a greater accumulation of polymorphonuclear leukocytes in the liver and a greater concentration of tumor necrosis factor-alpha (TNF-a) in plasma compared with similarly treated male mice .
Residing in normal liver are several types of innate immune cells, including NK cells, natural killer T (NKT) cells, and Kupffer cells (KCs) (Nemeth et al., 2009) . NK and NKT cells participate in innate immune responses through the release of rapidly induced cytokines, such as interferon-gamma (IFN-c), and through cell-mediated cytotoxicity via Fas-Fas ligand interactions, TNF-related apoptosis-inducing ligand receptors, and/or the exocytosis of cytotoxic granules. These hepatic innate immune cells could participate in the pathogenesis of drug-induced liver injury. Indeed, evidence exists for participation of NK cells in the hepatotoxicity of other drugs such as acetaminophen (Liu and Kaplowitz, 2006; Masson et al., 2008) . Injury in a model of mild HAL hepatotoxicity in mice was increased by polyinosinic:polycytidylic acid (poly(I:C)), a double-stranded RNA viral mimetic that induces the accumulation and activation of NK and NKT cells (Cheng et al., 2009) . However, the role of NK and NKT cells and IFN-c in the initiation of sexually dimorphic hepatotoxicity from HAL and other drugs associated with idiosyncratic liver injury remains unclear. Accordingly, we investigated the possibility that innate immune cells contribute to the sex disparity in HAL hepatotoxicity observed in mice.
METHODS
Materials. HAL (2-bromo-2-chloro-1,1,1,trifluoro-ethane) and highly refined low acidity olive oil were purchased from Sigma-Aldrich (St Louis, MO). Alanine aminotransferase (ALT) reagent was purchased from Thermo Electron Corp. (Louisville, CO). Gibco liver perfusion medium, Williams' medium E, hepatocyte wash medium, and fluorescein isothiocyanate-conjugated goat antirabbit immunoglobulin G (IgG) were purchased from Invitrogen (Carlsbad, CA). PBS and Hank's balanced salt solution (HBSS), each without Ca 2þ and Mg 2þ , were purchased from Lonza Walkersville, Inc. (Walkersville, MD). Dr Lance Pohl generously donated anti-TFA adduct rabbit serum (Satoh et al., 1985) . Horseradish peroxidase-conjugated goat antirabbit antibody was purchased from Santa Cruz (Santa Cruz, CA). Lympholyte mammal density separation medium and anti-asialo GM1 Ig fraction (anti-AsGm1) were purchased from Cedarlane Laboratories Limited (Hornby, Ontario, Canada). Rabbit Ig fraction was purchased from EMD Chemicals (Gibbstown, NJ). Clodronate-containing and empty liposomes were purchased from Encapsula Nano Sciences (Nashville, TN). Allophycocyanin (APC)-conjugated antimouse retinoic acid early inducible gene-1 (Rae-1) (pan specific) was purchased from R&D systems (Minneapolis, MN). Phycoerythrin (PE)-conjugated antimouse H-2D d , APC-Cy7 antimouse CD3e, isotype-matched antibodies, RBC lysis buffer, and fixation buffer were purchased from Biolegends (San Diego, CA). Higgins India ink was purchased from Utrecht (Canbury, NJ). Collagenase type II was purchased from Worthington Biochemical Co (Lakewood, NJ). Cell strainers of 100 lm were purchased from BD Biosciences (San Jose, CA).
Animals. BALB/cJ, BALB/cByJ, BALB/cJ CD1d KO, BALB/cJ IFNc KO, BALB Prf1 , TLR Lps-d , RAG1 NULL , ovariectomized (OVX), and shamoperated (SHAM) BALB/cJ mice were purchased from Jackson Laboratory (Bar Harbor, ME). They were housed under conditions of controlled temperature and humidity and 12 h light/dark cycle. Mice were given continual access to spring water and fed a standard chow (Rodent Chow/Tek 2018; Harlan Teklad, Madison, WI) ad libitum and allowed to acclimate for a week prior to use. Eight-to 12-week-old mice were fasted for 15 h prior to HAL administration, and food was returned after HAL administration. All procedures were carried out according to the humane guidelines of the American Association for Laboratory Animal Science and the University Laboratory Animal Research Unit at Michigan State University.
Experimental protocol. HAL solution was prepared as previously reported . Unless otherwise noted, mice fasted overnight were given 15 mmol/kg HAL or olive oil, ip. Vaginal cytology was analyzed prior to HAL administration by methods described elsewhere (Goldman et al., 2007) to classify mice according to estrous cycle phase. Mice were anesthetized with isoflurane and euthanized at various times after the administration of HAL; blood was drawn from the vena cava into a syringe containing sodium citrate (final concentration of 0.76%) for preparation of plasma. Plasma ALT activity, tissue processing, histopathological analysis, and TFA western analysis were performed as previously reported .
To reduce NK cell activity, mice were treated with 50 ll anti-AsGM1 or rabbit IgG, iv, 48 and 24 h before HAL administration. To deplete KCs, clodronate-containing or empty liposomes were administered 48 h before HAL administration. In some experiments, Higgins India ink (diluted 1:4 in saline) was injected iv 45 min before liver extraction to confirm KC depletion.
Isolation of hepatic lymphocytes. The liver was isolated and gently pressed through a 100-lm mesh filter. The liver cell suspension was collected in PBS and centrifuged at 50 3 g at 4°C for 3 min to remove parenchymal cells and debris. Supernatant was centrifuged at 350 3 g at 4°C for 5 min, and the pellet was resuspended in RBC lysis buffer according to the manufacturer's protocol. After two washes in PBS, the cells from five animals were combined in PBS and underlaid with lympholyte mammal density separation medium. Hepatic lymphocytes were obtained by centrifugation and washed in PBS.
Immunophenotyping of hepatic lymphocytes. After two washes in staining buffer (HBSS supplemented with 1% bovine serum albumin, 0.09% sodium azide, pH 7.6), the lymphocytes were incubated at 4°C for 30 min with antibodies to cell surface proteins, that is, either PE-conjugated CD49b mAb (clone DX5), APC-Cy7-conjugated CD3e mAb (clone 145-2C11), APCconjugated CD69 mAB (clone H1.2F3), or the appropriate isotype control. After two washes in staining buffer, the cells were fixed in fixation buffer for 20 min at 4°C. Data were collected on a BD FACS Canto II flow cytometer and analyzed with FLO JO software (Tree Star, Inc).
Isolation of primary hepatocytes for flow cytometry. The protocol for primary mouse hepatocyte isolation was adapted from that described by Renton (Renton, 1980) . In brief, mice were anesthetized with pentobarbital (50 mg/kg, ip), and their livers were retrograde perfused with Gibco liver perfusion medium through the inferior vena cava. Williams' medium E supplemented with 0.4 mg/ml collagenase type II was then perfused to digest the liver. The liver was combed gently to disaggregate the hepatocytes into Gibco hepatocyte wash medium. Cell debris was removed by straining the cell suspension through a 100-lm cell strainer. The hepatocytes were collected after centrifugation (50 3 g, 5 min) and washed twice in hepatocyte wash medium.
IFN-c analysis. The plasma concentration of IFN-c was measured using a BD OpEIA mouse IFN-c ELISA kit purchased from BD Biosciences (San Diego, CA).
Statistical analysis. Results are presented as mean ± SEM. A Student's t-test was performed on comparisons of two groups. For comparison of more than two groups, a 1-or 2-way ANOVA was used as appropriate after data normalization. The Student-Newman-Keuls test was performed to compare means in studies in which the ANOVA indicated statistical significance. The criterion for significance was p < 0.05 for all studies.
Probability binning was performed on flow cytometry data. In brief, this algorithm divides the control sample population into bins with the same number of events and then divides the test sample along the same boundaries and calculates the Chi-square value, v 2 , of the two-binned data sets. The probability 508 DUGAN ET AL. binning metric, or T(x), is derived from the v 2 value and provides a quantitative measurement of the probability that the populations are different . For our studies, T(x) > 3 was used as the criterion for significance.
RESULTS

Estrous Cycle and Ovarian Hormones Influence HAL-induced Hepatotoxicity
Estrous cycle phase was determined before the administration of HAL (5 mmol/kg, ip), and plasma ALT activity was evaluated 12 h later. The plasma ALT activity of HAL-treated mice in diestrus or proestrus was approximately 1000 U/l, whereas it was four to five times greater in HAL-treated mice in estrus (Fig. 1A) .
OVX and SHAM, vehicle (olive oil)-treated mice had plasma ALT activities < 100 U/l. All HAL (15 mmol/kg, ip)-treated SHAM mice developed severe liver injury as indicated by the 12 h plasma ALT activity of > 10,000 U/l and pronounced centrilobular hepatocellular necrosis on histopathological examination (Supplementary fig. 1 ). Similarly treated OVX mice developed mild injury with ALT activity of approximately 600 U/l (Fig. 1B) .
Cytokines in HAL-Treated Mice
In an earlier publication , HAL-treated female mice developed more severe liver injury with a more robust inflammatory response compared with male mice. IFN-c is an inflammatory cytokine released from NK and NKT cells. In the present study, there was no elevation in IFN-c concentration in plasma of vehicle (VEH)-treated mice at any time investigated (data not shown). In male mice, there was a mild elevation in plasma IFN-c concentration 24 h after HAL administration (Fig. 1C) . The plasma IFN-c concentration in female mice was significantly increased compared with male mice at 12 and 24 h (Fig. 1C) . Plasma IFN-c concentration was significantly reduced in OVX mice compared with SHAM mice 12 h after administration of HAL (Fig. 1D ).
HAL-Induced Liver Injury in IFN-c KO Mice
HAL exposure caused significant liver injury at 8 and 12 h in female wild-type (WT) mice as indicated by increased ALT Fig. 2A) . IFN-c KO mice were protected from severe HAL-induced liver injury at both times. Histopathological examination revealed that all the WT mice treated with HAL developed severe centrilobular necrosis in the livers collected 30 h after treatment (Fig. 2C) . The lesions were less severe in the livers of IFN-c KO compared with WT mice. Several of the IFN-c KO livers had no evidence of necrosis. In addition, livers of the protected IFN-c KO mice showed reduced intracellular staining of hepatocytes, suggesting that glycogen accumulation was absent in the HAL-treated WT mice.
A positive correlation has been reported between the severity of liver injury and the formation of TFA adducts in the livers of HAL-treated guinea pigs (Bourdi et al., 2001) . There was a similar degree of TFA adduct formation in livers from HAL-treated WT and HAL-treated IFN-c KO mice as determined by Western blot analysis (Fig. 2B) . TFA adducts were not detected in the livers of VEH-treated animals.
HMGB-1 Concentration and the Role of Toll-Like Receptor 4 in HAL Hepatotoxicity
High mobility group box-1 (HMGB-1) is released from injured cells and can signal inflammatory responses by binding to pattern recognition receptors, such as toll-like receptor 4 (TLR4) (van Zoelen et al., 2009) . Plasma HMGB-1 concentration did not change in VEH-treated animals at any time (data not shown). There was a slight increase in the plasma HMGB-1 concentration in HAL-treated male mice at 12 and 24 h (Fig. 3A) , whereas HMGB-1 concentration markedly increased in females 12 h after HAL administration.
Mice expressing a mutant TLR4 (Tlr4 Lps-d ) and their WT controls (BALB/cByJ) were given HAL, and plasma and liver samples were collected 24 h later. Plasma ALT activity and IFN-c concentration were reduced in HAL-treated Tlr4
Lps-d mice compared with HAL-treated WT mice (Figs. 3B and C). Histopathologically, there were fewer necrotic cells in the liver sections from Tlr4
Lps-d mice compared with those from WT mice (Supplementary fig. 2 ).
HAL Hepatotoxicity in KC-Depleted Mice
To deplete KCs, clodronate-encapsulated liposomes were injected into mice iv 48 and 24 h prior to HAL administration; empty liposomes were used as control. In a preliminary study, India ink was injected into mice to confirm effectiveness of clodronate treatment. India ink laden KCs were visible in the hepatic sinusoids of liver sections from mice pretreated with control liposomes, whereas they were not visible in clodronatepretreated animals, confirming inhibition of KC function (Supplementary fig. 3 ). There was no increase in plasma 
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ALT activity in VEH-treated mice given control liposomes or the clodronate-encapsulated liposomes. Plasma ALT activity was elevated in HAL-treated mice, and the increase was similar irrespective of clodronate inclusion in the liposomes (Fig. 4A) . Plasma IFN-c concentration was increased by HAL treatment similarly in clodronate-treated and control mice (Fig. 4B) .
HAL Hepatotoxicity in Mice Deficient in NKT Cells or Mature T and B Cells
Some findings have suggested the involvement of NKT cells in HAL hepatotoxicity in mice (Cheng et al., 2010) and of T and B cells in human HAL hepatotoxicity . By using genetically engineered mice that lack NKT cells (CD1d KO mice) or mice that lack T and B cells (RAG NULL mice), we tested whether these cell types were required for the development of severe HAL-induced liver injury. HAL treatment caused similar severe liver injury in WT and CD1d KO mice as indicated by increases in plasma ALT activity that were not significantly different between the strains at either 12 or 24 h (Fig. 4C) . Additionally, HAL treatment caused elevation in plasma ALT activity that was similar in WT and RAG NULL mice at 12 h (Fig. 4D) . Histopathological examination of livers revealed marked centrilobular necrosis in HAL-treated CD1d KO and RAG NULL mice ( Fig. 4E and F) .
HAL Hepatotoxicity in Mice with Reduced NK Cell Activity
Anti-AsGM1 decreases NK cell activity in BALB/c mice (Smyth et al., 2001) . CD69 is an early activation marker for T lymphocytes, B cells, NK, and NKT cells in response to stimuli. In this study, NK cells (DX5þ, CD3À) were evaluated for their expression of CD69 and CD107a, a marker that the cells have undergone degranulation. NK cells from antiAsGM1-treated mice had a decreased surface expression of CD69 (6.4%) and an increased expression of CD107a (16.2%) compared with those from IgG-treated mice (14.5 and 5.3%, respectively) (Supplementary fig. 4 ).
IgG-pretreated HAL-treated mice had plasma ALT activity > 7000 U/l at 12 h, indicating severe HAL hepatotoxicity, whereas after anti-AsGM1 pretreatment, HAL induced a milder hepatotoxicity with ALT activity of~1500 U/l (Fig. 5A) . By 24 h, the ALT activity was~5000 and~2500 U/l for IgG-and anti-ASGM1-pretreated HAL-treated mice, respectively. The plasma IFN-c concentration in HAL-treated mice was decreased markedly at both times by anti-AsGM1 pretreatment (Fig. 5B) .
NK cells are capable of causing granule-mediated cytotoxicity through the release of preformed cytotoxic proteins, perforin and granzyme B, which create pores in the membranes of target cells and mediate cell death (Berke, 1995) . Plasma ALT activity was not increased in response to HAL in mice with defective perforin (BALB Prf1 ) (Fig. 5C ). WT mice treated similarly developed severe liver damage. Plasma IFN-c concentration was significantly smaller in HAL-treated BALB Prf1 mice (~38 pg/ml) compared with similarly treated WT mice (~500 pg/ml) (Fig. 5D ).
Altered Surface Protein Expression on Hepatic NK Cells and Hepatocytes after HAL Administration In Vivo
The NK cell population (i.e., DX5þ, CD3À cells) was significantly decreased 8 h after HAL administration (18.6%) compared with vehicle-treated mice (22.4%) (Fig. 6A) . At the same time, the number of DX5þ, CD3À NK cells that were positive for CD69 increased significantly in HAL-treated (12.7%) compared with VEH-treated (9.6%) mice (Fig. 6B ).
FIG. 3 HMGB-1 release and the response to HAL in Tlr4
Lps-d mice. (A) Plasma HMGB-1 concentration was evaluated at various times after HAL treatment (15 mmol/kg, ip) in male and female mice (n ¼ 6 per group). VEHtreated animals had plasma HMGB1 concentrations < 5 pg/ml. #significantly different from sex-matched 6 h time point. *significantly different from timematched male and all other female groups. (B and C) Female WT BALB/cBYJ (WT) mice and Tlr4
Lps-d mice were treated with HAL (15 mmol/kg, ip). Plasma ALT activity and IFN-c concentration were evaluated 24 h after HAL treatment (n ¼ 4-5 per group). *significantly different from WT controls.
IFN-c AND NK CELLS IN HAL HEPATITIS
The expression of known ligands for NK receptors on hepatocytes was evaluated 8 h after HAL or VEH treatment. Administration of HAL was associated with a decrease in the percentage of hepatocytes that express H-2D d (80.3%) compared with 94.4% in VEH-treated mice (Fig. 6C) . In addition, the surface expression of Rae-1, a stress ligand for stimulatory receptors on NK cells, increased with HAL treatment (8.4%) compared with hepatocytes isolated from VEH-treated mice (3.7%) (Fig. 6D) .
DISCUSSION
The exact mechanisms of pathogenesis of hepatic IADRs, and HAL hepatitis in particular, are not known. The hapten hypothesis, in which HAL's reactive metabolite, TFA chloride, modifies proteins and/or lipids to form neoantigens that trigger an adaptive immune response on re-exposure, has received wide support. Much of the support for this proposed mechanism stems from the discovery of antibodies to TFA in some patients with HAL hepatitis and the observation that multiple exposures are a risk factor; however, these features do not apply to all cases of HAL hepatitis as reviewed previously . Accordingly, it remains possible that other processes could precipitate HAL hepatitis .
We recently characterized a model in which human risk factors (female sex, mature age, genetics, and fasting) were imposed on mice to enable the expression of severe HAL hepatotoxicity . Female sex is a risk factor for HAL hepatitis in humans as well as for the mild form of HAL-induced liver injury in mice Eghtesadi-Araghi et al., 2008; You et al., 2006) . In the mouse model presented herein, HAL sensitivity in mice was ovarian hormone-dependent as indicated by loss of HAL sensitivity in OVX mice (Fig. 1B and Supplementary fig. 1 ). Greater HAL sensitivity was also evident in mice in estrus (Fig. 1A) in which plasma concentration of progesterone is elevated compared with proestrus (high estrogen) and diestrus (low estrogen and progesterone) (Goldman et al., 2007) . Interestingly, a recent report demonstrated that mifepristrone (RU486), a potent progesterone antagonist, attenuated HAL-induced liver injury in mice (Masson et al., 2010) . Knowledge of the mechanisms of sex hormone-enhanced sensitivity to HAL-induced liver injury could provide insight into the pathogenesis of other IADRs for which female sex is a predisposing factor. Moreover, if sensitivity to HAL hepatitis also varies with estrous cycle stage in humans, then risk might be decreased by scheduling general anesthesia with HAL accordingly in women.
The sex disparity in sensitivity to HAL is unlikely to be due to hormonal influences on metabolic bioactivation of HAL because male and female mice had similar hepatic TFA adduct formation . Female mice that developed severe HAL hepatotoxicity had greater hepatic neutrophil accumulation and plasma TNF-a concentration , suggesting that a more robust inflammatory response occurs in females than in males.
IFN-c is a pleiotropic cytokine released mainly from cytotoxic T, NK, and NKT cells (Farrar and Schreiber, 1993) . The main functions of IFN-c are to activate macrophages and NK cells, upregulate major histocompatibility complex (MHC) class I and class II molecules, and participate in antiviral and antibacterial activities. IFN-c also promotes liver injury in humans, as demonstrated by the finding that administration of IFN-c to patients taking acetaminophen elevated liver enzyme activity in serum (Kellokumpu-Lehtinen et al., 1989) . Exogenous IFN-c administration caused apoptosis in a hepatocyte cell line (HepG2.2.15), and mice genetically engineered to overexpress IFN-c spontaneously developed hepatitis (Shi and Guan, 2009; Toyonaga et al., 1994) . IFN-c has also been implicated in the pathogenesis of liver injury in concanavalin A and acetaminophen animal models (Ishida et al., 2002; Tagawa et al., 1997) . In the present study, IFN-c KO mice were protected from severe HAL-induced liver injury ( Fig. 2A and  C) . Although IFN-c has been reported to decrease the activity of some cytochrome P450 enzymes (Renton et al., 1978) , the formation of TFA adducts was similar in WT and IFN-c KO mice (Fig. 2B) , suggesting no difference in HAL bioactivation. There are several proposed mechanisms by which IFN-c can enhance liver injury, including through the production of inflammatory mediators, the recruitment of inflammatory cells, and the suppression of liver regeneration (Gao, 2005) ; however, the mechanism by which IFN-c contributes to HAL-induced hepatotoxicity is not known.
TLRs are pattern recognition receptors that, on ligation, activate the innate immune response (Medzhitov and Janeway, 2000) . TLR4 binds to microbial ligands, such as lipopolysaccharide, and to endogenous ligands, such as heat shock proteins and HMGB-1, to initiate inflammatory cascades. TLR4 signaling is also involved in HAL-induced liver injury because Tlr4
Lps-d mice have an attenuated response (Fig. 3) . Because HMGB-1 concentration in plasma was elevated by HAL treatment and the elevation was greater in females than in refractory males (Fig. 3) , it is possible that HMGB-1 acts as a TLR4 agonist to enhance toxicity in HAL-treated female mice. The source of HMGB-1 is unknown, but it could arise from a direct effect of reactive TFA on hepatocytes.
NK cells participate in stress surveillance to destroy tumor cells, infected or aberrant host cells, foreign cells, and pathogens. In humans, NK cells (CD56þ, CD3À) constitute 30-50% of hepatic lymphocytes (Nemeth et al., 2009) . Similarly, a large number of hepatic NK cells were found in BALB/cJ mice, with 22% of hepatic lymphocytes immunophenotyped as DX5þ, CD3À NK cells (Fig. 6A) . Other reports indicate that 5-10% of the hepatic lymphocytes were NK cells in female, C57BL/6 mice (Gregoire et al., 2007) , a strain insensitive to HAL hepatitis . Thus, the disparity in resident NK cells in livers of BALB/c mice compared with C57/BL6 mice could contribute to the differences in immune response between the two strains (Heinzel et al., 1989) , and this could in turn underlie the difference in susceptibility to HAL hepatotoxicity. The observation that BALB/c mice and humans have similar proportions of hepatic NK cells could indicate that this strain is appropriate to model human NK cell-mediated liver pathology.
HAL administration decreased the numbers of DX5þ, CD3À NK cells in the hepatic lymphocyte pool at 8 (Fig.  6A ) and 24 h (data not shown). It is possible that this decrease resulted from increased sequestration of NK cells within the hepatic parenchyma that excludes them from the isolation procedure or that exposure to HAL alters the surface expression of DX5. The percentage of DX5þ, CD3À NK cells extracted from HAL-treated mice that were positive for CD69 was increased compared with NK cells isolated from vehicle-treated mice (Fig. 6B ). This suggests that HAL treatment can enhance hepatic NK cell activity in vivo.
Anti-AsGM1 treatment diminished antitumor activity attributed to NK cells (Habu et al., 1981) and decreased NK cellmediated cytotoxicity in vitro (Kasai et al., 1980; Masson et al., 2008) . In the present study, anti-AsGM1 treatment induced a phenotype shift in the expression of CD69 and CD107a, suggesting deactivation and degranulation of NK cells (Supplementary fig. 4B ). Anti-AsGM1 also abrogated HAL-induced plasma IFN-c increases compared with IgG-treated control mice and diminished liver injury at 12 h ( Fig. 5A and B) . These results suggest that IFN-c release was NK cell dependent. Additional support for a role of NK cells in HAL-induced liver injury came from the observations that mice with defective perforin were protected from HAL hepatotoxicity (Fig. 5C ) and that the increase in plasma IFNc was reduced in these mice compared with WT mice (Fig.  5D) . The finding presented here with anti-AsGM1 contrasts with another report in which anti-AsGM1 did not affect HAL hepatotoxicity (Cheng et al., 2010) . Some explanations for the disparity in these results lie in the anti-AsGM1 dosing regimen (one administration at 48-h in the study of Cheng et al. and two administrations in studies presented here) and the time at which liver injury was evaluated (15 and 12 h, respectively). With respect to the latter, it is noteworthy that, by 24 h in our studies, plasma ALT activity was returning toward baseline in IgGtreated mice but had not changed in anti-AsGM1-treated mice, so that the values were not different between the groups.
HAL hepatotoxicity depends on female sex hormones (Fig.  1B ) and NK cells (Fig. 5) -might there be a connection? This question was not addressed experimentally in these studies, but it is known that NK cells, as well as other leukocytes, express estrogen and progesterone receptors (Gilliver, 2010) and that sex hormones can modulate NK cell activity. For example, 17b-estradiol administration increased the intracellular IFN-c pool in NK cells stimulated with phorbol myristate acetate and ionomycin (Hao et al., 2007) . In addition, sexually dimorphic NK responses have been reported in humans and experimental animals. Females more rapidly reject skin allografts compared with males (Graff et al., 1969; Hirasawa and Enosawa, 1989) and suffer a smaller incidence of hepatocellular carcinoma (Bosch et al., 2005) ; both these events involve immune surveillance mediated by NK cells. Moreover, IFN-c, which is released by NK cells, and HMGB-1 were elevated in HALtreated intact female mice compared with HAL-treated male mice or with HAL-treated OVX mice (Figs. 1C and D and 3A) . This suggests that IFN-c and HMGB-1 might be part of a sexually dimorphic innate immune response in HAL-treated mice. These observations raise the possibility that interaction of NK cells and ovarian hormones contribute to HAL hepatotoxicity in this model.
Pharmacological and genetic approaches were used to evaluate the necessity of KCs, NKT, T, and B cells in the pathogenesis of severe HAL-induced liver injury. KCs are capable of promoting early IFN-c release; however, it has been reported (Cheng et al., 2009) and confirmed here (Fig. 4A ) that KCs are not necessary for the development of HAL hepatotoxicity in mice. Furthermore, KCs do not contribute significantly to HAL-induced IFN-c accumulation (Fig. 4B) . Cotreatment with poly(I:C), a double-stranded RNA mimic and ligand for TLR3, exacerbated HAL hepatotoxicity in a KCdependent manner (Cheng et al., 2009) . Therefore, KCs are not essential for the initiation of HAL hepatotoxicity but can be activated to exacerbate liver injury. The role of NKT cells is less clear. CD1d KO mice deficient in NKT cells develop severe HAL-induced liver injury (Fig. 4C ). This finding is in contrast to a report that CD1d KO mice were protected from HAL-induced liver injury (Cheng et al., 2010) . It is possible that differences in the two mouse models, such as the imposition of fasting and a different method of HAL preparation, could have led to disparate results. Our finding that RAG NULL mice deficient in mature T and B cells are capable of HAL bioactivation (Supplementary fig. 5 ) and develop severe HAL-induced liver injury (Fig. 4D) further confirms that cells with the RAG gene (T, B, and NKT cells) are not required for injury. However, these cells might upregulate the activity of cells that mediate HAL-induced liver injury. For example, NK cells have Fc receptors that bind to Ig, suggesting a mechanism whereby plasma antibodies could modulate NK cell activity. Interestingly, NK cells from nude mice, which also lack T and B cells, required preactivation with poly(I:C) to cause virusinduced liver injury, whereas prior activation was not required in WT mice (Liu et al., 2000) . This underscores the highly integrated nature of the two arms of the immune system and also suggests that elevated Ig levels, which are considered to be diagnostic of a humoral-mediated toxicity, might enhance NK cell activity.
Because the bioactivation of HAL occurs primarily within hepatocytes, it is possible that the resulting TFA adducts induce an intracellular stress response that targets affected cells for cytotoxic killing by surveillant immune cells (Fig. 7) . This is an attractive concept because hepatic NK cells physically interact with hepatic parenchymal cells (Wisse et al., 1976) . One way that a cell can communicate its stressed status to adherent immune effector cells such as NK cells is by changing the expression of MHC class I and MHC class I-like molecules on its plasma membrane (Gleimer and Parham, 2003) . MHC class I-like molecules expressed on the surface of epithelial cells signal intracellular distress to surveillent immune cells. In mice, MHC class I-like molecules, such as Rae-1 and Mult-2, expressed during cell stress, bind to NKG2D stimulatory receptors on NK cells (Cerwenka et al., 2000) , and induce NK cell activity (Jinushi et al., 2003) . HAL-treated hepatocytes had increased Rae-1 expression compared with hepatocytes from vehicle-treated mice (Fig. 6D) . MHC class I molecules are genetically similar to MHC class I-like proteins, but their function has diverged to include antigen presentation in cellmediated immunity. Additionally, MHC class I molecules expressed on epithelial cells (e.g., hepatocytes) downregulate NK cell activity (Jamieson et al., 2002) and the loss of epithelial MHC class I molecules activates NK cells (Ljunggren and Karre, 1986) . This is known as the ''missing selfhypothesis.'' After HAL treatment, there were fewer hepatocytes expressing H-2D d , a murine MHC class I molecule (Fig.  6A) . Therefore, the direct interaction and signaling of HALstressed hepatocytes with cytotoxic NK cells is one way in which the innate immune system might lead to severe HALinduced hepatotoxicity in females.
IFN-c AND NK CELLS IN HAL HEPATITIS
The results of this study significantly enhance our understanding of the effector cells that contribute to the sexually dimorphic HAL response in mice. Ovarian hormones predispose female mice to severe HAL hepatotoxicity mediated through IFN-c and probably HMGB-1. NK cells contribute to the onset of pathogenesis in an IFN-c-and perforin-dependent manner. IFN-c and the phenotype of circulating NK cells might ultimately provide serum biomarkers and potential therapeutic screens for individuals sensitive to HAL hepatitis and possibly other drug-induced hepatotoxicities.
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